<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">Importantly, even the 
 <italic>pen2 edr1</italic> mutant is still not fully susceptible to 
 <italic>Ctro</italic>
 <sup>
  <xref ref-type="bibr" rid="CR10">10</xref>
 </sup>, because strong postinvasive resistance is newly activated once 
 <italic>Ctro</italic> enters epidermal cells of the mutants defective in the preinvasive resistance. We reported previously that 
 <italic>Arabidopsis cyp79B2 cyp79B3</italic> double mutant is fully susceptible to the nonadapted pathogen 
 <italic>Ctro</italic>, i.e., the mutant is defective in both preinvasive and postinvasve resistance
 <sup>
  <xref ref-type="bibr" rid="CR10">10</xref>
 </sup>. CYP79B2 and CYP79B3 are key enzymes for the biosynthesis of tryptophan (Trp)-derived antimicrobial metabolites. CYP79B2/CYP79B3 convert Trp into indole-3-acetaldoxime (IAOx)
 <sup>
  <xref ref-type="bibr" rid="CR11">11</xref>
 </sup>, and this precursor is then converted into several compounds for antimicrobial immunity, such as PEN2 substrates indole-glucosinolates (IGs), PAD3 (PHYTOALEXIN-DEFICIENT3)-dependent camalexin, and 4-hydroxy-ICN (4-OH-ICN) whose biosynthesis requires CYP82C2
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>â€“
  <xref ref-type="bibr" rid="CR14">14</xref>
 </sup>. We have shown that the 
 <italic>pen2 pad3</italic> mutant is partially defective in postinvasive resistance to 
 <italic>Ctro</italic>, indicating that the 
 <italic>Arabidopsis</italic> phytoalexin, camalexin, is a critical factor for this.
</p>
